ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,051.25
      -0.54%
      US Tech 100
      21,060.00
      0.00%
      Dow Jones
      43,914.12
      -0.53%
      Brent Oil
      73.445
      0.32%
      Bitcoin
      100,004.95
      -0.06%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Oric Pharmaceuticals Inc (ORIC) Quote

      Oric Pharmaceuticals Inc

      Oric Pharmaceuticals Inc (ORIC)

      NASDAQ
      8.43
      0.00
      (0.00%)
      Closed December 13 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      8.43
      Bid
      7.97
      Ask
      8.96
      Volume
      -
      0.00 Day's Range 0.00
      6.33 52 Week Range 16.65
      Market Cap
      594.879M
      Previous Close
      8.43
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      408,375
      Shares Outstanding
      70,566,950
      Dividend Yield
      -
      PE Ratio
      -5.91
      Earnings Per Share (EPS)
      -1.43
      Revenue
      -
      Net Profit
      -100.7M

      About Oric Pharmaceuticals Inc

      ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company h... ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely, ORIC-101, ORIC-944, ORIC-114, and ORIC-533. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.oricpharma.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Oric Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ORIC. The last closing price for Oric Pharmaceuticals was $8.43. Over the last year, Oric Pharmaceuticals shares have traded in a share price range of $ 6.33 to $ 16.65.

      Oric Pharmaceuticals currently has 70,566,950 shares outstanding. The market capitalization of Oric Pharmaceuticals is $594.88 million. Oric Pharmaceuticals has a price to earnings ratio (PE ratio) of -5.91.

      Ask ADVFN Intelligence (AI)

      ORIC Latest News

      More News

      ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

      SOUTH SAN FRANCISCO and SAN DIEGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address...

      November 25 2024
      GlobeNewswire Inc.

      Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

      November 14 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 12 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 12 2024
      Edgar (US Regulatory)

      ORIC® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates

      Presented preclinical data further supporting the potential best-in-class profile of ORIC-114 to treat EGFR exon 20 insertions and other atypical mutations at the EORTC-NCI-AACR Conference...

      November 12 2024
      GlobeNewswire Inc.

      Form SC 13G - Statement of Beneficial Ownership by Certain Investors

      November 08 2024
      Edgar (US Regulatory)

      ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

      SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 04, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that...

      November 04 2024
      GlobeNewswire Inc.

      ORIC® Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

      SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 01, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that...

      November 01 2024
      GlobeNewswire Inc.

      ORIC® Pharmaceuticals Presents Data Further Supporting Potential Best-In-Class Profile of ORIC-114 to Treat EGFR Exon 20 Insertions and Other Atypical Mutations at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

      SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Oct. 23, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that...

      October 23 2024
      GlobeNewswire Inc.

      ORIC® Pharmaceuticals Announces Presentation at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

      SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Oct. 09, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that...

      October 09 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-1.39-14.15478615079.8210.218.42132509.09916044CS
      4-0.49-5.49327354268.9210.358.1053078929.28178423CS
      12-2.73-24.462365591411.1611.78.1054083759.6204754CS
      260.536.708860759497.912.836.334906899.34960216CS
      52-0.27-3.103448275868.716.656.3349150410.19602442CS
      156-6.22-42.45733788414.6517.262.364426847.47860081CS
      260-17.57-67.57692307692640.812.3636727511.52737465CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AALAmerican Airlines Group Inc
      $ 17.24
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 70.13
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 2.41
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.879999
      (0.00%)
      		0
      AALAmerican Airlines Group Inc
      $ 17.24
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 70.13
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 2.41
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.879999
      (0.00%)
      		0
      AALAmerican Airlines Group Inc
      $ 17.24
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.1326
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 70.13
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 2.41
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.879999
      (0.00%)
      		0

      ORIC Discussion

      View Posts
      Monksdream Monksdream 3 months ago
      ORIC under $10
      👍️0
      Monksdream Monksdream 5 months ago
      ORIC under $10
      👍️0
      Monksdream Monksdream 5 months ago
      ORIC under $10
      👍️0
      Monksdream Monksdream 7 months ago
      ORIC 10Q due 5/6
      👍️0
      Monksdream Monksdream 7 months ago
      ORIC under $10
      👍️0
      Monksdream Monksdream 9 months ago
      ORIC 10Q due 3/16
      👍️0
      Monksdream Monksdream 9 months ago
      ORIC new 52 week high
      👍️0
      Monksdream Monksdream 9 months ago
      ORIC new 52 week high
      👍️0
      Monksdream Monksdream 9 months ago
      ORIC new 52 week high
      👍️0
      Monksdream Monksdream 10 months ago
      ORIC new 52 weewk high
      👍️0
      Monksdream Monksdream 11 months ago
      ORIC new 52 week high
      👍️0
      TheFinalCD TheFinalCD 2 years ago
      $ORIC LOOKS LIKE $6 COMING
      👍️0
      makinezmoney makinezmoney 2 years ago
      $ORIC: Tapped $5.40....... still got steam

      It ain't over yet





      GO $ORIC
      👍️0
      DH112 DH112 2 years ago
      Today is green fields
      👍️0
      TheFinalCD TheFinalCD 2 years ago
      Pfizer will pay $4.65 per share for 5,376,344 of Oric's common shares, for a total of $25 million. The companies plan to move the treatment into a Phase 2 clinical trial in combination with elranatamab, Pfizer's investigational treatment of multiple myeloma

      https://finance.yahoo.com/news/oric-pharmaceuticals-announces-clinical-development-224800151.html
      👍️0
      makinezmoney makinezmoney 2 years ago
      $ORIC: 5.25 now........................... lets get to $10

      I know you can do it babyyyyyyyyyyyyyyyyy


      GO $ORIC
      👍️0
      makinezmoney makinezmoney 2 years ago
      $ORIC : Now at 4.90

      YESsssssssssssssss............ this is very impressive news with deal with Pfizer.

      Me likes it


      GO $ORIC
      👍️0
      crudeoil24 crudeoil24 2 years ago
      Shares of Oric Pharmaceuticals Inc. jumped nearly 60% to $4.79 in premarket trading Thursday after the company agreed to sell $25 million in shares to Pfizer Inc.

      The clinical-stage oncology company said Wednesday evening that Pfizer has agreed to buy nearly 5.4 million shares of Oric's common stock for $4.65 apiece.

      The investment is part of a clinical development collaboration between the two companies on a Phase 2 study examining Oric's ORIC-533 treatment for multiple myeloma, the companies said.

      The companies said the collaboration would potentially advance the treatment into a combination study with Pfizer's elranatamab, an investigational treatment for multiple myeloma.


      Write to Dean Seal at dean.seal@wsj.com


      (END) Dow Jones Newswires

      December 22, 2022 07:25 ET (12:25 GMT)
      👍️0
      makinezmoney makinezmoney 2 years ago
      $ORIC: BOOOoommmmmmm........... Pfiizer invests $25Milly in ORIC

      Letssssssss goooooooooooooooooo.


      Added 5k shares here at 4.30

      Great NEWS


      https://www.tipranks.com/news/oric-pharmaceuticals-nasdaqoric-stock-spikes-on-pfizer-deal

      GO $ORIC
      👍️0

      Your Recent History

      NASDAQ
      ORIC
      Oric Pharmaceuticals
      LSE
      63VJ
      Lloyds Bk. 49
      ASX
      GGEDC
      Grand Gulf Energy
      Delayed Upgrade Clock